Trial · NCT02427880
Role of Acetazolamide and Hydrochlorothiazide Followed by Furosemide in Treating Nephrotic Edema
NCT02427880, Phase 4, Completed, Shiraz University of Medical Sciences
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Role of Acetazolamide and Hydrochlorothiazide Followed by Furosemide in Treating Nephrotic Edema. Trials, record NCT02427880. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02427880
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Role of Acetazolamide and Hydrochlorothiazide Followed by Furosemide in Treating Nephrotic Edema
- NCT number
- NCT02427880
- Status
- Completed
- Phases
- Phase 4
- Enrollment
- 20 participants, actual
- Lead sponsor
- Shiraz University of Medical Sciences
- Conditions
- Nephrotic Syndrome, Edema
- Interventions
- Acetazolamide and Hydrochlorothiazide Followed by Furosemide, Furosemide and Hydrochlorothiazide Followed by Furosemide
- First posted
- 2015-04-28
- Last updated
- 2016-02-23
Source ClinicalTrials.gov
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from baseline in weight at the end of third week | Baseline and at the end of the third week | |
| Secondary | Change from baseline in systolic and diastolic blood pressure at the end of third week | Baseline and at the end of the third week | |
| Secondary | Change from baseline in serum sodium at the end of third week | Baseline and at the end of the third week | |
| Secondary | Change from baseline in serum potassium at the end of third week | Baseline and at the end of the third week | |
| Secondary | Change from baseline in blood urea nitrogen at the end of third week | Baseline and at the end of the third week | |
| Secondary | Change from baseline in serum creatinine at the end of third week | At the start and at the end of the third week | |
| Secondary | Change from baseline in serum albumin at the end of third week | Baseline and at the end of the third week | |
| Secondary | Change from baseline in urine sodium at the end of third week | Baseline and at the end of the third week | |
| Secondary | Change from baseline in urine potassium at the end of third week | Baseline and at the end of the third week | |
| Secondary | Change from baseline in 24-hour urine volume at the end of third week | Baseline and at the end of the third week |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 23146978 | BACKGROUND |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02427880
GET https://conductscience.org/api/trials/v1/NCT02427880/registered